Cellxlife signed a licensing agreement for a cell-based vaccine from Mayo Clinic that aims to teach the body’s immune system to recognize and…

Tecvayli (teclistamab) extended survival and kept disease under control longer than standard treatments in patients with relapsed or refractory multiple myeloma, meaning the…

Adding iadademstat, an experimental blood cancer drug, to standard of care treatment for acute myeloid leukemia (AML) appeared to be safe and effective in…